Financials • Specialty Insurers
$3.97 ▲ +0.08
(+2.06%)
MKT CAP: $204.6M • VOL: 49.5K
52W L $1 52W H $7
ROARABLE / RQD
D- • 40/100
PIOTROSKI
2 / 9
XHG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 |
|---|---|---|
| Revenue (Total Sales) | $51.3M | $41.1M |
| YoY Revenue Growth % | +24.9% | — |
| Gross Profit | — | — |
| Gross Margin % | — | — |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | -$101.2M | -$83.9M |
| Operating Margin % | -80.0% | -80.0% |
| Net Income (GAAP) | -$105.1M | $0 |
| EBITDA (Normalized) | — | — |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | -$1.6M | -$1.4M |
| Capital Expenditures (CapEx) | — | — |
| Free Cash Flow (FCF) | -$1.6M | -$1.4M |
| FCF Margin % | -3.2% | -3.4% |
| Return on Invested Capital (ROIC %) | — | — |
| Cash & Short-Term Equivalents | — | — |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | — | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR XHG.